Epigenomics of human colon cancer.

DNA methylation exerts critical effects on gene-expression regulation in normal cells, and alterations on the normal methylation patterns characterize, and likely contribute, to cancer development and progression. The complete understanding of the distinctiveness, role and dynamics of the cancer cell epigenome has been hindered so far by technical limitations, and new, whole-genome approaches are required. Here we review the methods that have permitted us glimpses of the colon cancer methylome and outline future directions that will eventually lead researchers to identify the altered epigenetic patterns in cancer cells.

[1]  Zsolt Tulassay,et al.  Identification and Validation of Colorectal Neoplasia–Specific Methylation Markers for Accurate Classification of Disease , 2007, Molecular Cancer Research.

[2]  Jeffrey S. Morris,et al.  Concordant CpG island methylation in hyperplastic polyposis. , 2002, The American journal of pathology.

[3]  A. Camargo,et al.  Colorectal cancer "methylator phenotype": fact or artifact? , 2005, Neoplasia.

[4]  P. Jones,et al.  Epigenetic regulation and nucleosome positioning in the human TATA-less IL-1α promoter , 2008, Genes and Immunity.

[5]  A. Feinberg,et al.  Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk , 2003, Science.

[6]  F. Bazzoli,et al.  Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer. , 2003, Cancer research.

[7]  Thomas Mikeska,et al.  Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene , 2008, Epigenetics & Chromatin.

[8]  C. Plass,et al.  DNA motifs associated with aberrant CpG island methylation. , 2006, Genomics.

[9]  J. Herman,et al.  GATA-4 and GATA-5 Transcription Factor Genes and Potential Downstream Antitumor Target Genes Are Epigenetically Silenced in Colorectal and Gastric Cancer , 2003, Molecular and Cellular Biology.

[10]  Wei-Dong Chen,et al.  CpG island methylation in aberrant crypt foci and cancers from the same patients , 2005, International journal of cancer.

[11]  Jian Yu,et al.  Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. , 2004, World journal of gastroenterology.

[12]  C. Plass,et al.  HLTF gene silencing in human colon cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Herman,et al.  Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. , 2000, Cancer research.

[14]  Hyeon Joo Lee,et al.  Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia , 2004, Laboratory Investigation.

[15]  Dao-rong Wang,et al.  Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. , 2008, World journal of gastroenterology.

[16]  W. Lam,et al.  Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells , 2005, Nature Genetics.

[17]  J. Herman,et al.  DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. , 2001, Human molecular genetics.

[18]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Minucci,et al.  Epigenomic profiling of cancer cells. , 2009, The international journal of biochemistry & cell biology.

[20]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[22]  M. Washington,et al.  The aberrant methylation of TSP1 suppresses TGF‐β1 activation in colorectal cancer , 2008, International journal of cancer.

[23]  S. Baylin,et al.  p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3 , 1995, Nature Genetics.

[24]  M. Paz,et al.  Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases. , 2003, Human molecular genetics.

[25]  T. Rauch,et al.  The MIRA method for DNA methylation analysis. , 2009, Methods in molecular biology.

[26]  J. Issa,et al.  CpG island methylation in aberrant crypt foci of the colorectum. , 2002, The American journal of pathology.

[27]  Hong Duan,et al.  Role for DNA methylation in the control of cell type–specific maspin expression , 2002, Nature Genetics.

[28]  J. Herman,et al.  Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme , 2007, Journal of Neuro-Oncology.

[29]  Andreas von Bubnoff,et al.  Next-Generation Sequencing: The Race Is On , 2008, Cell.

[30]  M. Vieth,et al.  DAPK promotor methylation is an early event in colorectal carcinogenesis. , 2006, Cancer letters.

[31]  J. Costello,et al.  Genome-epigenome interactions in cancer. , 2007, Human molecular genetics.

[32]  M. Paz,et al.  Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. , 2005, Human molecular genetics.

[33]  A. Feinberg,et al.  Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. , 2004, Gastroenterology.

[34]  J. Rogers,et al.  DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.

[35]  J. Greally,et al.  The HELP assay. , 2009, Methods in molecular biology.

[36]  M. Fraga,et al.  Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer , 2006, Oncogene.

[37]  R. Lothe,et al.  ADAMTS1, CRABP1, and NR3C1 Identified as Epigenetically Deregulated Genes in Colorectal Tumorigenesis , 2006, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[38]  J. Herman,et al.  GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer , 2009, Clinical Cancer Research.

[39]  Jun Yu,et al.  WNT5A Exhibits Tumor-Suppressive Activity through Antagonizing the Wnt/β-Catenin Signaling, and Is Frequently Methylated in Colorectal Cancer , 2008, Clinical Cancer Research.

[40]  S. Ropero,et al.  A microRNA DNA methylation signature for human cancer metastasis , 2008, Proceedings of the National Academy of Sciences.

[41]  C. Plass,et al.  SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[43]  M. Esteller.  Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.

[44]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[45]  I. Simon,et al.  Evidence for an instructive mechanism of de novo methylation in cancer cells , 2006, Nature Genetics.

[46]  A. Schatzkin,et al.  Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. , 2004, Journal of the National Cancer Institute.

[47]  Andrew J. Wilson,et al.  Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors. , 2005, Cancer research.

[48]  M. Esteller.  Epigenetics in cancer. , 2008, The New England journal of medicine.

[49]  M. Fraga,et al.  Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. , 2007, Cancer research.

[50]  C. Compton,et al.  Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. , 2004, Cancer research.

[51]  M. Perucho,et al.  Genetics supersedes epigenetics in colon cancer phenotype. , 2003, Cancer cell.

[52]  Joobae Park,et al.  Aberrant Methylation of APC, MGMT, RASSF2A, and Wif-1 Genes in Plasma as a Biomarker for Early Detection of Colorectal Cancer , 2009, Clinical Cancer Research.

[53]  A. Feinberg,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[54]  M. Fraga,et al.  Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer , 2005, Nature Genetics.

[55]  S. Clark,et al.  High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.

[56]  Thomas D. Otto,et al.  Tumour class prediction and discovery by microarray-based DNA methylation analysis , 2002 .

[57]  Wei Jiang,et al.  High-throughput DNA methylation profiling using universal bead arrays. , 2006, Genome research.

[58]  R. Durbin,et al.  A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis , 2008, Nature Biotechnology.

[59]  P. Laird,et al.  DNA methylation analysis by MethyLight technology. , 2001, Methods.

[60]  M. Toyota,et al.  Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. , 2000, Cancer research.

[61]  D. Sidransky,et al.  PGP9.5 methylation in diffuse-type gastric cancer. , 2006, Cancer research.

[62]  P. Guldberg,et al.  In-tube DNA methylation profiling by fluorescence melting curve analysis. , 2001, Clinical chemistry.

[63]  Thomas Lengauer,et al.  CpG Island Methylation in Human Lymphocytes Is Highly Correlated with DNA Sequence, Repeats, and Predicted DNA Structure , 2006, PLoS genetics.

[64]  W. Reik,et al.  Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer , 2002, Oncogene.

[65]  E. Ballestar,et al.  Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells. , 2007, Cancer research.

[66]  Wei Dong Chen,et al.  Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer , 2004, Nature Genetics.

[67]  F. Slack,et al.  MicroRNAs as potential cancer therapeutics , 2008, Oncogene.

[68]  Hiroyuki Yamamoto,et al.  Differential involvement of the hypermethylator phenotype in hereditary and sporadic colorectal cancers with high‐frequency microsatellite instability , 2002, Genes, chromosomes & cancer.

[69]  C. Lofton-Day,et al.  Comparative DNA methylation analysis in normal and tumour tissues and in cancer cell lines using differential methylation hybridisation. , 2007, The international journal of biochemistry & cell biology.

[70]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[71]  Kevin L. Gunderson,et al.  Highly parallel genomic assays , 2006, Nature Reviews Genetics.

[72]  Matty P. Weijenberg,et al.  A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.

[73]  S. Toyooka,et al.  Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. , 2002, Cancer research.

[74]  R. Beart,et al.  Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. , 1995, Cancer research.

[75]  P. Malfertheiner,et al.  Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers. , 2005, Neoplasia.

[76]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[77]  H. Fiegl,et al.  SFRP2 methylation in fecal DNA—a marker for colorectal polyps , 2007, International Journal of Colorectal Disease.

[78]  F. Sato,et al.  Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. , 2002, Cancer cell.

[79]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[80]  S. Horvath,et al.  Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.

[81]  J. Meyerhardt,et al.  CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci , 2008, Modern Pathology.

[82]  H. Bayley,et al.  Continuous base identification for single-molecule nanopore DNA sequencing. , 2009, Nature nanotechnology.